Latest News
These are CLL Ireland’s latest news posts from Facebook – but make sure to visit our CLL Ireland Facebook page for older posts.
This content isn't available at the moment
When this happens, it's usually because the owner only shared it with a small group of people or changed who can see it, or it's been deleted.cllsociety.org
And we can do more than hope. We can advocate for effective prophylaxis with protective anti-COVID antibodies to protect those like the late Colin Powell who cannot make our own.This content isn't available at the moment
When this happens, it's usually because the owner only shared it with a small group of people or changed who can see it, or it's been deleted. Tomorrow! October 15th: The Right Tests at the Right Time! Testing to guide treatment in all phases of CLL has never been better! Hear the stunning first-hand accounts of CLL patients Tammi Garrett and David Klausmeyer, whose treatment regimens were radically changed by CLL Society’s Test Before Treat™ campaign and the critical information it brings. Drs. Brian Hill and Ryan Jacobs will also explain the use of Bone Marrow Biopsies, CT scans, physical exams for lymph nodes and enlarged spleen, testing for Measurable Residual Disease (uMRD) to measure effectiveness of treatment, and the importance of routine of routine blood work and monitoring to keep you healthy! Build your CLL test knowledge and engage more deeply in the care you are getting for your CLL. Register here. bit.ly/3mKk0ae
Nitin Jain, M.D., is an Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas, USA. He earned his medical degree from the All India Institute of Medical Sciences (AIIMS), New Delhi, India in 2002. He then moved to the United States and completed his Internal Medicine residency training at the Medical College of Wisconsin, Milwaukee, Wisconsin. He then completed a year of clinical fellowship in Leukemia at MD Anderson Cancer Center followed by another year of Leukemia research fellowship at the Memorial Sloan-Kettering Cancer Center in New York. He then pursued fellowship in Hematology/Oncology at the University of Chicago. He was then recruited as a faculty member in the Department of Leukemia at MD Anderson Cancer Center in 2012. Dr. Jain treats patients with acute and chronic leukemia with focus of patients with chronic lymphocytic leukemia (CLL) and acute lymphoblastic leukemia (ALL). Dr. Jain research interests focus on new drug development for patients with leukemia, especially CLL and ALL. Dr. Jain is Principal Investigator of several investigator-initiated phase I-II clinical trials, including combination targeted therapies (ibrutinib and venetoclax) in CLL, combination of ibrutinib and chemotherapy (iFCG regimen) in CLL, checkpoint inhibitors in CLL and Richter transformation, trial with JAK2 inhibitor ruxolitinib in Ph-like ALL, novel CD22 antibody drug conjugate in B-ALL, venetoclax + chemotherapy in B- and T-ALL, and off-the-self allogeneic CART in B-ALL. He has published papers in prominent journals including Journal of Clinical Oncology, Blood, Clinical Cancer Research, Cancer, Leukemia Lymphoma, Leukemia Research and others. He has won many awards during his career including Sardari Lal Kalra Gold Medal in Microbiology and Merit Award from the American Society of Clinical Oncology (ASCO). He was ranked first at the national level in India in the medical school![]()
![]()
us06web.zoom.us/webinar/register/WN_EyoGQiCmSzuHqHvimK3C1Q
us06web.zoom.us
Speaker: Prof. Nitin Jain Nitin Jain, M.D., is an Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas, USA. He earned his medical degree from the All India Institute of Medical Sciences (AIIMS), New Delhi, India in 2002. He then mo... Lorna Warwick is CEO of the Lymphoma Coalition, a worldwide network of patient groups with a full or partial focus on providing support to patients with lymphoma. In this wide-ranging interview, Warwick highlights the progress made in lymphoma treatment in recent years and the work still to be done to better integrate authentic patient experiences and insights into the drug development, regulation, and assessment processes, especially for cutting-edge therapies such as CAR-T.
PharmaBoardroom | Lorna Warwick - CEO, Lymphoma Coalition
pharmaboardroom.com
Lorna Warwick is CEO of the Lymphoma Coalition, a worldwide network of patient groups with a full or partial focus on providing support to patients with lymphoma. In this wide-ranging interview, Warwick highlights the progress made in lymphoma treatment in recent years and the work still to be done.... Here is some more information about the 3rd vaccine shot from #HSE that may be helpful for those of us with weak immune systems.![]()
![]()
www2.hse.ie/screening-and-vaccinations/covid-19-vaccine/get-the-vaccine/weak-immune-system/?utm_s...
Weak immune system and COVID-19 vaccines - additional dose
www2.hse.ie
If you have a weak immune system, you may be offered an additional COVID-19 vaccine dose to give you better protection. Find out if you need one and how to get it www.facebook.com/291934661006674/posts/1838619726338152/If you are immunosuppressed or immunocompromised you may be offered another COVID-19 vaccine dose to give you better protection. ![]()
![]()
Having a weak immune system means you may not have responded as well to your vaccine as other people. This additional dose should help protect you from becoming severely ill from COVID-19.![]()
![]()
Learn more: bit.ly/2YtayQx #COVIDVaccines #ForUsAll
Our friends in Irish Cancer Society have provided some clarity about the 3rd vaccine. This is very important for our blood cancer community.![]()
![]()
www.cancer.ie/cancer-information-and-support/coronavirus-and-cancer-info-for-patients-families-vo...
COVID-19 vaccine and cancer patients
www.cancer.ie
COVID-19 vaccine and cancer patients Share Share via Twitter Share via Facebook Share via Whatsapp Share via LinkedIn Share via Email Latest information on the Covid-19 vaccination rollout for people affected by cancer Statement from Irish Cancer Society COVID-19 vaccine and cancer patients What we....
Uncovering the Value of Real-World Data for Blood Cancer
Published News